Bupropion hydrochloride and Daliresp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bupropion hydrochloride (bupropion hydrochloride) and Daliresp (roflumilast). Common drug interactions include pollakiuria among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Bupropion hydrochloride and Daliresp. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Bupropion hydrochloride?

Bupropion hydrochloride has active ingredients of bupropion hydrochloride. It is often used in depression. eHealthMe is studying from 21,496 Bupropion hydrochloride users. Check the latest studies of Bupropion hydrochloride.

What is Daliresp?

Daliresp has active ingredients of roflumilast. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 4,722 Daliresp users. Check the latest studies of Daliresp.

On Jul, 17, 2026

37 people who take Bupropion hydrochloride and Daliresp together, and have interactions are studied.

Bupropion hydrochloride and Daliresp drug interactions.

What are the common drug interactions of Bupropion Hydrochloride and Daliresp, by gender? *:

female:

Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Poor quality sleep
Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Headache (pain in head)
Arthralgia (joint pain)
Respiratory tract infection
Chest discomfort
Diarrhoea
Gastritis (inflammation of stomach)

male:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Bone density decreased
Dizziness
Fatigue (feeling of tiredness)
Osteonecrosis (death of bone)
Decreased appetite
Nausea (feeling of having an urge to vomit)
Chronic kidney disease
Emotional distress
Hip arthroplasty

What are the common drug interactions of Bupropion Hydrochloride and Daliresp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Rash pruritic (redness with itching)
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Respiratory tract infection
Scar
Sputum discoloured
Tremor (trembling or shaking movements in one or more parts of your body)
Visual impairment
Vomiting
Wheezing (a high-pitched whistling sound made while you breath)

60+:

Fatigue (feeling of tiredness)
Headache (pain in head)
Diarrhoea
Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
Infusion related reaction
Multiple allergies (allergy to multiple agents)
Pain
Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
Procedural nausea
Productive cough

What are the existing conditions these people have? *

Asthma: 9 people, 24.32%
Immunodeficiency Common Variable: 3 people, 8.11%
Hiv Infection: 3 people, 8.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.11%
Nausea (feeling of having an urge to vomit): 2 people, 5.41%
Multiple Allergies (allergy to multiple agents): 2 people, 5.41%
Migraine (headache): 2 people, 5.41%
Infection: 2 people, 5.41%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 2 people, 5.41%
High Blood Pressure: 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Bupropion hydrochloride and Daliresp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously